Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update
Hrvoje Roguljić, Vjera Ninčević, Kristina Bojanić, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress
Bradley Field Bale, Amy L. Doneen, Pierre P. Leimgruber, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 18
Genetic and Epigenetic Intersections in COVID-19-Associated Cardiovascular Disease: Emerging Insights and Future Directions
Hussein Sabit, Borros Arneth, Afaf Altrawy, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 485-485
Open Access
Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight
Yoshimasa Tokuchi, Goki Suda, Naoki Kawagishi, et al.
Hepatology Research (2023) Vol. 53, Iss. 7, pp. 595-606
Closed Access | Times Cited: 9
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells
Elena Grossini, Carlo Smirne, Sakthipriyan Venkatesan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10197-10197
Open Access | Times Cited: 9
Shear-wave elastography to predict hepatocellular carcinoma after hepatitis C virus eradication: A systematic review and meta-analysis
Giorgio Esposto, Paolo Santini, Linda Galasso, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 10, pp. 1450-1460
Open Access | Times Cited: 3
Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis
Wenchang Yang, Yaxin Wang, Peng Zhang, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 13
Impact of direct‐acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers
Laurent Lam, Hélène Fontaine, Nathanaël Lapidus, et al.
Pharmacoepidemiology and Drug Safety (2022) Vol. 32, Iss. 4, pp. 486-495
Open Access | Times Cited: 9
Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR
Mina Nakagawa, Yasuhiro Asahina, Sei Kakinuma, et al.
Journal of Gastroenterology (2022) Vol. 58, Iss. 4, pp. 299-310
Closed Access | Times Cited: 8
Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury
Irina Gîrleanu, Anca Trifan, Laura Huiban, et al.
Life (2022) Vol. 12, Iss. 7, pp. 1036-1036
Open Access | Times Cited: 7
Effects of sustained viral response on lipid in Hepatitis C: a systematic review and meta-analysis
Tingting Mei, Xiaojie Huang, Shan Tang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Trends in Hospitalizations of Patients with Hepatitis C Virus in Poland between 2012 and 2022
Agnieszka Genowska, Dorota Zarębska‐Michaluk, Krystyna Dobrowolska, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5618-5618
Open Access | Times Cited: 1
Hepatitis C and Thalassemia: A Story with (Almost) a Happy Ending
Raffaella Origa
Pathogens (2023) Vol. 12, Iss. 5, pp. 683-683
Open Access | Times Cited: 3
Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort)
Tangui Barré, Marc Bourlière, Clémence Ramier, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 6135-6135
Open Access | Times Cited: 5
Preclinical Models and Promising Pharmacotherapeutic Strategies in Liver Fibrosis: An Update
Tea Omanović Kolarić, Lucija Kuna, Marina Čović, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 5, pp. 4246-4260
Open Access | Times Cited: 2
Cardiovascular outcomes in hepatitis C virus infected patients treated with direct acting antiviral therapy: a retrospective multi-institutional study
Victor Chien‐Chia Wu, Chien‐Hao Huang, Chun-Li Wang, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 6, pp. 507-514
Closed Access | Times Cited: 1
Association between treatment of hepatitis C virus and risk of cardiovascular disease among insured patients with the virus in the United States
Wei Wang, Chao Chen, Vincent Lo Re, et al.
Pharmacoepidemiology and Drug Safety (2023) Vol. 32, Iss. 10, pp. 1142-1151
Open Access | Times Cited: 1
Cognitive Performance in Asymptomatic Elderly People with Hepatitis C: The Role of Education
Max Kopti Fakoury, Sergio L. Schmidt, Carlos Eduardo Brandão‐Mello, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4588-4588
Open Access | Times Cited: 1
Relationship Between Hepatitis C Infection and Treatment Status and Coronavirus Disease 2019–Related Hospitalizations in Georgia
Ana Aslanikashvili, Charlotta Rylander, Tinatin Manjavidze, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 3, pp. e694-e699
Open Access
Impact des antiviraux à action directe sur l'athérosclérose subclinique chez les patients atteints d’une hépatite C chronique
Sarra Laabidi, M Medhioub, A Khsiba, et al.
La Tunisie Médicale (2024) Vol. 102, Iss. 3
Open Access
Identifying Gaps in the Treatment Guidelines for Hepatitis C in Peru to Meet International Standards: A Narrative Review
Jose Armando Gonzales Zamora, Carlos Quispe‐Vicuña, Martin E. Reátegui-Garcia, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3867-3867
Open Access
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry
Tommaso Clemente, Sara Diotallevi, Davide Minisci, et al.
Journal of Antimicrobial Chemotherapy (2024)
Closed Access
Successful treatment of Japanese hemophilia patient co-infected with HIV and HCV genotype 4a by glecaprevir/pibrentasvir therapy
Ken Sato, Yuki Kanayama, Yuichi Yamazaki, et al.
Clinical Journal of Gastroenterology (2021) Vol. 14, Iss. 6, pp. 1725-1732
Closed Access | Times Cited: 2
Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
Mohammad Ramadan, Filomena Boccia, Simona Maria Moretto, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5781-5781
Open Access | Times Cited: 1
Adverse Impact of HIV-1 on Long-term Outcomes Following HCV DAA Treatment: Final Results of ACTG A5320, the Viral Hepatitis C Infection Long-term Cohort Study (VHICS)
David Wyles, Minhee Kang, Roy M. Matining, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 3
Open Access
Relation of Intima Media Thickening of Carotid Arteries with Parameters of Lipid Profile in Chronic Hepatitis C Patients
Talat Samreen, Asma Aijaz, Shazia Fahmi, et al.
Journal of Bahria University Medical and Dental College (2023) Vol. 13, Iss. 02, pp. 167-171
Open Access
Page 1 - Next Page

Scroll to top